key: cord-0942070-nsrm0axa
authors: Qi, Di; Yan, Xiaofeng; Tang, Xumao; Peng, Junnan; Yu, Qian; Feng, Longhua; Yuan, Guodan; Zhang, An; Chen, Yaokai; Yuan, Jing; Huang, Xia; Zhang, Xianxiang; Hu, Peng; Song, Yuyan; Qian, Chunfang; Sun, Qiangzhong; Wang, Daoxin; Tong, Jin; Xiang, Jianglin
title: Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality, China: a retrospective, descriptive, multiple-center study
date: 2020-03-03
journal: nan
DOI: 10.1101/2020.03.01.20029397
sha: 510ecab01c66bc2a911abcf67451ec482ed18a05
doc_id: 942070
cord_uid: nsrm0axa

Background：In January 19, 2020, first case of 2019 novel coronavirus (2019-nCoV) pneumonia (COVID-19) was confirmed in Chongqing municipality, China. Methods：In this retrospective, descriptive, multiple-center study, total of 267 patients with COVID-19 confirmed by real-time RT-PCR in Chongqing from Jan 19 to Feb 16, 2020 were recruited. Epidemiological, demographic, clinical, radiological characteristics, laboratory examinations, and treatment regimens were collected on admission. Clinical outcomes were followed up until Feb 16, 2020. Results：267 laboratory-confirmed COVID-19 patients admitted to 3 designated-hospitals in Chongqing provincial municipality from January 19 to February 16, 2020 were enrolled and categorized on admission. 217 (81.27%) and 50 (18.73%) patients were categorized into non-severe and severe subgroups, respectively. The median age of patients was 48.0 years (IQR, 35.0-65.0), with 129 (48.3%) of the patients were more than 50 years of age. 149 (55.8%) patients were men. Severe patients were significantly older (median age, 71.5 years [IQR, 65.8-77.0] vs 43.0 years [IQR, 32.5-57.0]) and more likely to be male (110 [50.7%] vs 39 [78.0%]) and have coexisting disorders (15 [30.0%] vs 26 [12.0%]). 41 (15.4%) patients had a recent travel to Hubei province, and 139 (52.1%) patients had a history of contact with patients from Hubei. On admission, the most common symptoms of COVID-19 were fever 225(84.3%), fatigue (208 [77.9%]), dry cough (189 [70.8%]), myalgia or arthralgia (136 [50.9%]). Severe patients were more likely to present dyspnea (17 [34.0%] vs 26 [12.0%]) and confusion (10 [20.0%] vs 15 [6.9%]). Rales (32 [12.0%]) and wheezes (20 [7.5%]) are not common noted for COVID-19 patients, especially for the non-severe (11 [5.1%], 10 [4.6%]). 118 (44.2%). Most severe patients demonstrated more laboratory abnormalities. 231 (86.5%), 61 (22.8%) patients had lymphopenia, leukopenia and thrombocytopenia, respectively. CD4+T cell counts decrease was observed in 77.1 % of cases, especially in the severe patients (45, 100%). 53.1% patients had decreased CD+3 T cell counts, count of CD8+T cells was lower than the normal range in part of patients (34.4%). More severe patients had lower level of CD4+ T cells and CD+3 T cells (45 [100.0%] vs 29[56.9%], 31 [68.9%] vs 20 [39.2%]). Most patients had normal level of IL-2, IL-4, TNF-α and INF-γ, while high level of IL-6 and IL-17A was common in COVID-19 patients (47 [70.1%], 35 [52.2%]). Level of IL-6, IL-17A and TNF-α was remarkably elevated in severe patients (32 [84.2%] vs 15 [51.7%], 25 [65.8%] vs 10 [34.5%], 17 [44.7%] vs 5 [17.2%]). All patients received antiviral therapy (267, 100%). A portion of severe patients (38, 76.0%) received systemic corticosteroid therapy. Invasive mechanical ventilation in prone position, non-invasive mechanical ventilation, high-flow nasal cannula oxygen therapy was adopted only in severe patients with respiratory failure (5[10.0%], 35[70.0%], 12[24.0%]). Traditional Chinese medicine was adopted to most of severe patients (43,86.0%). Conclusion:Our study firstly demonstrated the regional disparity of COVID-19 in Chongqing municipality and further thoroughly compared the differences between severe and non-severe patients. The 28-day mortality of COVID-19 patients from 3 designed hospitals of Chongqing is 1.5%, lower than that of Hubei province and mainland China including Hubei province. However, the 28-mortality of severe patients was relatively high, with much higher when complications occurred. Notably, the 28-mortality of critically severe patients complicated with severe ARDS is considerably as high as 44.4%. Therefore, early diagnosis and intensive care of critically severe COVID-19 cases, especially those combined with ARDS, will be considerably essential to reduce mortality.

than the normal range in part of patients (34.4%). More severe patients had lower level of CD4 + T cells and CD + 

Our study firstly demonstrated the regional disparity of COVID-19 in Chongqing municipality and further thoroughly compared the differences between severe and non-severe patients. The 28-day mortality of COVID-19 patients from 3 designed hospitals of Chongqing is 1.5%, lower than that of Hubei province and mainland China including Hubei province. However, the 28-mortality of severe patients was relatively high, with much higher when complications occurred. Notably, the 28-mortality of critically severe patients complicated with severe ARDS is considerably as high as 44.4%. Therefore, early diagnosis and intensive care of critically severe COVID-19 cases, especially those combined with ARDS, will be considerably essential to reduce mortality.

Coronavirus; Novel coronavirus (2019-nCoV); COVID-19; Chongqing; Clinical characteristics Introduction:

Since December of 2019, a cluster of cases of pneumonia with unknown etiology All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint occurred in Wuhan, Hubei Province, China 1 Recently, there are some studies demonstrating the clinical characteristics and epidemiology of COVID-19 patients in Wuhan or throughout China [5] [6] [7] [8] . As Chongqing is reported to be one of the major cities imported passengers from Wuhan in China from December 16, 2019 9 . Given the regional disparity of COVID-19, we aim to describe epidemiological, clinical, laboratory, and radiological features, treatment, and prognosis of COVID-19 patients in Chongqing municipality, and compare the differences between non-severe and severe patients, which may unravel risk factors associated with 28-day mortality and further suggest a specific therapeutic intervention for patients with COVID-19 in Chongqing municipality, China.

A retrospective, descriptive, multiple-center study on the clinical characteristics of All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Respiratory specimens, including nasopharyngeal swab and bronchoalveolar lavage fluid (BALF), or anal swab specimens were collected at admission to detect the presence of 2019-nCoV by real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) assay in designated authoritative laboratories of local centers for disease control and prevention 12 . Bacterial, fungal, and pathogenic microorganism test in respiratory and blood samples was routinely performed. Cytokines and lymphocyte subsets in peripheral blood were measured by fluorescence-labeled flow cytometry (Beckman, Cell Lab Quanta SC)

The epidemiological, demographic, clinical, laboratory, radiological, treatment and outcomes data from confirmed COVID-19 patients' medical and nursing records were obtained and analyzed. The date of disease onset was defined as the day when the symptoms were noticed. Clinical outcomes were followed up to February 16, 2020.

Data were entered into a computerized database and were checked by two physicians.

All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity. author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

The Laboratory and radiologic findings are shown in Table 2 author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which was not peer-reviewed) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which was not peer-reviewed) is the 

All patients were treated in isolated wards, among whom critically severe patients were treated in intensive care unit with negative pressure wards. The treatment, complications and outcomes are shown in Table 3 author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

By February 16, 2020, the health commission of Chongqing announced that among 551 confirmed COVID-19 patients in Chongqing, 207(37.57%) patients were discharged, 5 patients (0.91%) were died and 339(61.52%) patients were still in All rights reserved. No reuse allowed without permission.

author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint hospital for treatment， lower than that of Hubei province and mainland China including Hubei province (Fig.4) . In our study, 103(38.6%) patients had been discharged and 4(1.5%) patients had died, and all other patients were in hospital. The For severe patients, the duration from admission to developing ARDS is only 3 days (IQR, 2.0-5.0), and the 28-mortality of severe patients was 8.0% (4/50), with much higher when complications occurred (14.8%, [4/27] ). Notably, the 28-mortality of critically severe patients complicated with severe ARDS is considerably as high as 44.4% (4/9). Therefore, early diagnosis and intensive care of critically severe COVID-19 cases will be considerably essential to reduce complications and mortality.

In December 2019, COVID-19 firstly occurred in Wuhan, Hubei Province, China.

The disease has rapidly spread from Wuhan to worldwide 1 . On January 30, the World Health Organization has declared the COVID-19 outbreak as a public health emergency due to this rapid infection spreads. However, as one of the major cities imported passengers from Wuhan in China 9 , the regional characteristics of COVID-19

in Chongqing municipality were not reported so far. Our presents study, to our knowledge, firstly portrayed the epidemiological, demographic, clinical, radiological, laboratory characteristics, treatment regimens and clinical outcomes of COVID-19 patients in Chongqing municipality, China. And we further compared the numerous differences between severe and non-severe patients in Chongqing municipality. The 28-day mortality of COVID-19 patients from 3 designed hospitals of Chongqing municipality is 1.5%, approximately consistent with the official fatality rate 0.91%, lower than the 28-day mortality of mainland China including Hubei province (2.51%

[1770/70548]), reported by national official statistics as for February 16th, 2020 All rights reserved. No reuse allowed without permission.

author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Two more researches including COVID-19 cases based on the big data from the whole country delineated the clinical and epidemiological characteristics of COVID-19 in nationwide 8, 13 . The clinical courses and outcomes of critically ill COVID-19 patients was recently reported 14 .

In our study, the majority critically severe patients are older and male, consistent with gender difference in previous researches 6, 13, 14 Compared with patients who had a definite direct exposure to Huanan seafood market in Wuhan, the epidemics in Chongqing has transmitted to the coexistence of imported cases and local sporadic or clustered cases. As the strong epidemic control in Hubei was implemented, clustered cases or family aggregation cases gradually compose the majority of confirmed cases in Chongqing. Although small part of patients in Chongqing had coexisting chronic disease, relatively less frequent than that of patients in Wuhan 6 , severe patients were more likely to suffer from underlying comorbidities (diabetes, obesity, cardiovascular and cerebrovascular diseases), All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint resulting in the deficiency in innate and adaptive immunity of these patients. Among the common comorbidities, we found a significant portion of patients in Chongqing suffered from overweight and obesity, which is more common in severe patients.

Obesity-induced chronic inflammation status is well documented to contribute to the progress of multiple diseases 18 . Large epidemiological studies have shown that BMI was associated with increased risk of acute respiratory distress syndrome (ARDS) and length of hospital stay, which has already been used in lung injury prediction score (LIPS) to help physicians identify at-risk patients for developing ALI 19 . Therefore, elderly male patients with a history of smoke and underlying comorbidities are at increased risk of becoming critically severe if they are suffered from COVID-19 infection, which deserves more attention and intensive care treatment. Therefore, the atypical patients and asymptomatic carriers deserves more attention to avoid delayed or missed diagnosis. Moreover, rales and wheezes are scarcely noted when lung auscultation was performed, due to the lack of sputum or mucus, especially for non-severe patients. Further comparison between the severe and non-severe patients found that severe patients are more likely to suffer from dyspnea and confusion symptoms on disease onset, which may suggest severe complications such All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint as respiratory failure or septic shock, and is of great value of early identification of critically severe cases. The median durations from symptoms onset to laboratory diagnosis and hospital admission were 4 days and 7 days, with obvious longer time for severe cases, which may lead to the poor outcome due to delayed medical interventions. In general, COVID-19 in severe cases progresses rapidly to lethal complications (ARDS, septic shock, acute cardiac injury, refractory metabolic acidosis and so on), even leading to death. Our study demonstrates that the median interval from symptoms onset to ARDS of severe cases was much shorter than that of non-severe cases. It has been demonstrated that poor populations always endured a disproportionate burden of disease and death from infectious diseases like influenzas 21 .

A great number of death cases in our study were poorly-educated elders with chronic comorbidities, their illness deteriorated rapidly to severe ARDS within several days, presented as suddenly occurred severe hypoxaemia, malignant arrhythmia, cardiac and respiratory arrest, unfortunately death, despite of timely rescue including invasive ventilation and other advanced medical interventions. Therefore, early diagnosis and management of critically severe COVID-19 cases, especially poorly-educated elderly male with chronic comorbidities, should be vigorously advocated.

Regarding to laboratory tests, consistent with most reports, peripheral lymphocytopenia is the most crucial and common feature for COVID-19 infection. In our study, most patients suffered from varying degrees of lymphocytopenia, especially for critically severe patients. Lymphocytopenia is also a prominent feature for patients author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint proinflammatory Th17 and cytotoxic CD8 T cells, partially accounts for the severe immune injury in death patient 26 . The phenomenon that T cell counts reduced and functionally exhausted has been reported in previous study, which indicates high risk for further deterioration of COVID-19 27 . In our study, a progressive decline of lymphocytes and CD4 positive T cells was observed during the deterioration of illness. presented as elevated levels of infectious parameters, but other abnormalities were less common. While, severe patients obviously manifested more prominent abnormalities, suggesting multiple organ dysfunction and poor outcomes. Additionally, severe cases suffered from lower albumin and hemoglobin, suggesting the importance of nutrition supportive treatments. As for radiologic presentations, more attention should be paid to the cases without obvious radiological abnormalities on admission, so as to avoid the miss or delayed diagnosis. Therefore, it is crucial important to take symptoms, laboratory findings, radiologic findings into account to make an integrated and thorough judgment. The MuLBSTA score, an efficient early warning model for predicting mortality in viral pneumonia 30 , needs further validation in the future practice.

All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint Currently, no specific treatment available has been advocated for coronavirus infection. As most of patients in Chongqing were non-severe, antiviral therapy was commonly adopted among these patients. Empirical antibiotic therapy was merely administered to few patients with bacterial infection evidence, and ordinary oxygen therapy was supplied only if hyoxemia occurred. As for the severe cases, author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint not associated with a significant improvement in survival 35 . Therefore, it is still too early to judge the efficiency of these therapy, much more studies are still needed In summary, our study firstly demonstrated the regional disparity of COVID-19 in Chongqing and further thoroughly compared the differences between severe and non-severe patients in Chongqing municipality, China. The 28-day mortality of COVID-19 patients from 3 designed hospitals of Chongqing municipality is 1.5%, approximately consistent with the official fatality rate 0.91%, lower than that of Hubei province and mainland China including Hubei province. Early isolation, early diagnosis, early management, combined with the strong epidemic control in Hubei and the effective prevention of local cluster outside Hubei might collectively contribute to the marked reduced 28 day-mortality in Chongqing municipality.

However, for severe patients, the 28-mortality was relatively high, with much higher when complications occurred. Notably, the 28-mortality of critically severe patients complicated with severe ARDS is considerably as high as 44.4%. Thus, early diagnosis and intensive care of critically severe COVID-19 cases, especially those combined with ARDS, will be considerably essential to reduce mortality.

Mahallawi WH, Khabour OF, Zhang Q, Makhdoum HM, Suliman BA. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint author/funder, who has granted medRxiv a license to display the preprint in perpetuity. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint author/funder, who has granted medRxiv a license to display the preprint in perpetuity. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint Fig.1 Chest computed tomography of a 56 years old female patient of non-sever COVID-19 in Chongqing on admission. 

Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chinese medical journal

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England journal of medicine

SARS and MERS: recent insights into emerging coronaviruses

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan

Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv

The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: A data-driven correlational report. Travel medicine and infectious disease

Acute respiratory distress syndrome: the Berlin Definition

A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)

Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine

Prevalence of Comorbidities in the Middle East Respiratory Syndrome Coronavirus (MERS-CoV): A Systematic Review and Meta-analysis

Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection

Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv

The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism

All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint medical center (No.2020-015-01-KY), Chongqing three gorges central hospital (No.2020-13) and Qianjiang central hospital of Chongqing (No.2020-07).

This study was supported by National Natural Science Foundation of China (Grant NO. 81670071) and the National Natural Science Foundation for Young Scholars of China (Grant NO. 81800083).All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.01.20029397 doi: medRxiv preprint